Former Portfolio Companies

VectivBio is a spin out of Therachon (acquired by Pfizer in 2019), that will focus on conditions caused by well understood molecular alterations that can be targeted with transformational therapeutics.   The company was acquired in 2023 by Ironwood Pharmaceuticals.

IPO in 2021 (TK: VECT), Acquired by Ironwood 2023 (TK: IRWD) Basel, Switzerland visit www.vectivbio.com